TrialPloS one2022

Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.

Ben Gombe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.